Pages

Tuesday, July 1, 2014

Mesothelioma Pleurocentesis

Mesothelioma patients experience many uncomfortable symptoms associated with their disease. One of the most debilitating symptoms of pleural mesothelioma is the build-up of fluid in the pleura space around the lungs. This collection of fluid makes it very difficult to breathe and also can cause severe pain. It greatly impacts the quality of life for the patient and can make it difficult to do every day tasks. Although there is no known cure for mesothelioma cancer, this type of treatment can relieve uncomfortable symptoms.
The best way to relieve this discomfort is to have the fluid removed by means of a pleurocentesis. Also known as a thoracentesis, this type of mesothelioma surgery can be performed as many times as necessary and is done in an outpatient setting, in most cases.

What to Expect

Before this procedure is performed, the patient will probably undergo a CT scan or some other sort of imaging test so that the mesothelioma doctor can determine the amount of fluid present. After that, an appointment will be scheduled for the procedure.
During the pleurocentesis, the patient sits up and generally leans on a table. The doctor cleans and numbs the area where a long, thin needle will be inserted to draw out the fluid, generally between the ribs. Little pain is felt during the procedure though the patient may experience a feeling of pressure. Once an ample amount of the fluid is removed, the needle is withdrawn and the area is covered with a bandage. The procedure generally takes less than 30 minutes total, depending on the amount of fluid to be removed. However, the patient may remain longer for monitoring purposes.
Once sent home, the patient will be instructed to rest for at least 24 hours in order to avoid complications, which could include bleeding or infection. In very rare cases, pneumothorax - the collapse of the affected lung - could occur.


Mesothelioma Pleurectomy


Pleurectomy is a procedure in which the mesothelial lining of the lung and chest cavity is removed. Surgery is typically performed by thoracic or cardiothoracic surgeons and may involve concurrent resection of the pericardium (mesothelial lining of the heart) or the peritoneum (mesothelial lining of the abdominal cavity). Each of these internal structures performs a similar function and is composed of similar cells.
Patients may undergo pleurectomy for any number of conditions, including malignant pleural mesothelioma, pleural effusion, or trauma. Mesothelioma is a rare, aggressive cancer and relatively asymptomatic in its earlier stages.
One of the primary symptoms of mesothelioma is pleural effusion, a condition that is created when fluid excreted by mesothelial cells builds up and puts pressure on the lung and chest wall. While pleurocentesis may be used to reduce fluid buildup and relieve symptoms, often full pleurectomy is recommended to provide more sustaining patient comfort. Pleurectomy is particularly common in concert with more extensive procedures, including pneumonectomy, extrapleural pneumonectomy, and other cardiothoracic resections.
During surgery, an incision is made in the area where the disease is located. The surgeon then removes the pleura. In some cases, diseased tissue from the affected lung is also removed (pneumonectomy).
Pleurectomy is an invasive procedure that will typically require a total anesthetic. Following surgery, the surgeon will conduct a post-operative interview during which they will likely recommend deep breathing and frequent changing of bandages to prevent infection.

Mesothelioma Extrapleural Pneumonectomy


Extrapleural pneumonectomy is a surgical treatment for malignant mesothelioma. It involves the removal of a lung, a portion of the diaphragm, the linings of the lungs and heart (parietal pleura and pericardium). This is a serious operation that is performed only on those patients whose cancer is confined to the chest cavity, and are deemed to be sufficiently healthy.
Extrapleural pneumonectomy inhibit metastasis in mesothelioma cases. Patients who undergo this operation enjoy significant increases their mesothelioma survival rate when treated with radiation and chemotherapy in addition to the surgery.
This mesothelioma surgery is nonetheless controversial and quite dangerous. Some doctors believe that the risks outweigh the benefits. Such risks include:
  • hemorrhage (internal bleeding)
  • respiratory failure
  • pneumonia
  • empyema (accumulation of pus in the chest cavity)
  • blood clotting in the veins of the inner thigh or leg
  • death
Mesothelioma cancer may recur after the operation as well. Alternatives include pleurectomy (partial removal of a lung) and other conventional mesothelioma treatment.
Because the procedure is so demanding from a technical standpoint, extrapleural pneumonectomies are usually done in larger, better-equipped medical centers The procedure itself requires that the patient is put under general anesthesia. A large incision in the chest is made and the sixth rib may be removed in order to expose the diseased lung and open up the working space. Next, the diseased lung is collapsed and its major blood vessels and main bronchial tube are clamped; these will be stitched or stapled shut later on. The diseased lung is then removed, along with the pleural lining, pericardium and parts of the diaphragm. These are replaced with patches synthetic material. Finally, the chest incision is sutured shut, and a temporary drain is inserted into the chest cavity.

Mesothelioma Pneumonectomy


A pneumonectomy is the surgical removal of all or part of a lung, usually performed as a cancer treatment. Because this mesothelioma surgery will significantly reduce the patient's breathing capacity, mesothelioma doctors will choose less extreme options if available. Before committing to a pneumonectomy, the oncologist will order extensive testing in order to insure that the remaining lung will have enough capacity to take over the respiration process.
A pneumonectomy may either be of the traditional or extrapleural type. A traditional pneumonectomy consists of removing the affected lung only; an extrapleural pneumonectomy involves the removal of the diseased lung along with a portion of the pericardium (membrane covering the heart and affected in pericardial mesothelioma), part of the diaphragm, and the parietal pleura (membrane lining the chest cavity) on the same side of the chest. This is sometimes the best treatment option for malignant pleural mesothelioma patients.
An extrapleural pneumonectomy can slow metastasis (spreading) in mesothelioma cases and allow the patient to breathe more easily. Studies indicate that mesothelioma patients treated with a combination of extrapleural pneumonectomy, radiotherapy, and mesothelioma chemotherapy enjoy better survival rates. Of all mesothelioma treatments, extrapleural pneumonectomy allows for the highest survival rates.
Extrapleural pneumonectomies are usually done in larger cancer centers with better facilities, since these procedures are quite complicated. The operation requires general anesthesia; the surgeon begins by making a large incision in the chest and may need to remove the sixth rib in order to help expose the diseased lung and make enough space for the procedure. Next, the surgeon collapses the diseased lung, ties off its major blood vessels, and clamps the main bronchial tube, which will later be stapled. The diseased lung is then cut away. Lining of the chest wall that is removed as well as parts of the pericardium and diaphragm are replaced by patches of synthetic material. The chest incision is closed with sutures, and a temporary drain is inserted into the chest cavity.
Patients are administered an epidural anesthetic for pain in the days following the operation; recovery normally requires a two-week hospital stay.

Mesothelioma Surgery

When an individual is diagnosed with cancer, treatment options will be one of the first topics discussed with the oncologist. The available treatment options will vary from patient to patient depending on the type of mesothelioma that has been diagnosed and the stage that the disease has progressed to at the time of diagnosis. Mesothelioma, in particular, is a very serious and aggressive form of cancer for which treatment options have traditionally been quite limited.
When a recently-diagnosed mesothelioma patient is presented with options for treatment, surgery may be recommended. There are different forms of mesothelioma surgery and some are proposed as a curative measure, while others are designed to relieve symptoms of the disease that can be quite debilitating and interfere with the patient's quality of life.

Curative Surgeries

Due to the nature of mesothelioma and the fact that by the time a diagnosis is made the disease has usually reached an advanced stage, a surgical cure is not a likely option. However, in some cases, surgery is suggested in order to remove as much of the cancer as possible and is often followed by other mesothelioma treatments such as chemotherapy and/or radiation.
Ideally, candidates for these surgeries will be in the early stages of the disease where the tumor is still fairly localized and metastasis has not occurred. In addition, the patient will need to be in overall good health and free of other medical issues that can complicate these procedures and lengthen the recovery period. Extant medical issues—heart disease, hypertension, and diabetes—are often an issue with older mesothelioma patients. These issues can further limit treatment options and make aggressive surgical procedures a less favorable choice.
However, if the doctor determines that the patient is strong enough, the following surgeries may be recommended:

Pneumonectomy

A pneumonectomy is a radical surgery that involves the removal of the diseased lung. Candidates for this procedure have mesothelioma that is limited to just one lung. Performed under general anesthesia, this is quite a complicated surgery that can take up to three hours to perform. During the surgery, the diseased lung will be deflated and after several steps to prevent bleeding into the chest cavity, the lung is removed through a fairly large incision. At times, part of the fifth rib must be removed as well to provide better access to the lung. A drainage tube will then be inserted and the incision closed. The patient will remain in surgical intensive care for about 48 hours and then in a regular hospital room for one to two weeks, depending on complications, which are very common with this procedure and occur in some 50 percent of patients. It can also take up to six months for the healthy lung to learn to do the job of both lungs; hence, shortness of breath is a considerable problem for pneumonectomy patients and many take several months to resume their normal activity.

Extrapleural Pneumonectomy

Recommended only in rare cases, this surgery involves the removal of the affected lung as well as the areas surrounding it. It is a very risky surgery and carries with it a long list of complications including heart failure and serious gastrointestinal problems. The procedure is similar to that of the pneumonectomy and candidates are those who are in the earlier stages of mesothelioma, which has not spread to the lymph nodes. Candidates should also be in otherwise good health. The recovery period can last for up to a half-year or longer.

Pleurectomy

A pleurectomy involves the removal of the visceral and parietal pleura, which is the lining of the lungs. This may be used as a potential curative procedure but also may be performed to address pleural effusion, the build-up of fluid in the lungs. This surgery is performed under general anesthesia. To perform a pleurectomy, an incision is made in the affected area, which has been numbed with a local anesthesia. Through this incision, both the inner and outer linings of the lungs are removed. The surgeon may also opt to remove the lung tissue beneath the pleura. The procedure is sometimes followed by chemo or radiation to remove any remaining cancerous tissue. The post-surgery stay for the pleurectomy is generally about a week but may be longer if complications arise during or after surgery, including bleeding or infection.

Palliative Surgeries

Surgeries that relieve mesothelioma symptoms like pain and other problems associated with mesothelioma disease are as follows:

Pleurocentesis

This procedure is used to address pleural effusion, the build-up of fluid in the pleural area surrounding the lungs. The fluid can make it very painful and difficult for a mesothelioma patient to breathe. The procedure is performed in an outpatient area by means of a long, thin needle that is inserted into the pleural space to withdraw fluid. The patient may return home a few hours after the procedure is complete and when the doctor is satisfied that no adverse reactions will occur.

Paracentesis

Essentially the same procedure as pleurocentesis, a paracentesis is performed to remove fluid that has collected in the abdominal area to provide more comfort to patients with peritoneal mesothelioma.

Pleurodesis

This more serious surgery is used to halt the build-up of fluid for a longer amount of time and involves inserting talc into the pleural space. The talc causes inflammation and stops the fluid from collecting, often for as long as a few years. It is an inpatient procedure performed under general anesthetic, requiring a hospital stay of at least 72 hours, during which time a chest tube may remain in place to drain any additional fluids. Recovery time is 6 to 8 weeks for most patients.

Conventional Treatments


Conventional mesothelioma therapies include surgery, radiation and chemotherapy. You should keep in mind that if you choose one course of action for mesothelioma treatment, you may preclude other courses. All of your options should be considered as soon as possible.

Mesothelioma Surgery

Mesothelioma Surgery Depending on the stage of a mesothelioma, surgery may be used to remove the cancer and some of the surrounding tissue. Often, however, an operation is not appropriate and the patient may have only minimally invasive procedures to relieve symptoms. A thoracentesis, where fluid in the chest is removed by placing a needle into the chest cavity, may be done to make a patient more comfortable. Sometimes talc or an antibiotic may be injected into the chest cavity to try to prevent the fluid from returning. These techniques are successful in controlling the fluid, at least temporarily, in as many as 90% of patients. Because pleural fluid can compress the lung and cause shortness of breath, these procedures can help patients breathe more easily, however, they do not cure the cancer. In the case of peritoneal mesothelioma, a needle may be inserted into the abdomen to drain the fluid. Similarly, a needle inserted into the pericardium (sac around the heart) can drain the fluid caused by pericardial mesothelioma and help relieve circulatory problems. However, draining this fluid may result in complications. Sometimes the cancer cells spread along the needle path, and a tumor nodule may form under the skin of that area.
Surgery for mesothelioma may be performed for one of two reasons: for palliation (to relieve pain and discomfort caused by the tumor), or to cure. Palliative surgery is typically done in cases where the tumor has already spread beyond the mesothelium and is difficult to completely remove, or in cases where the patient is too ill to tolerate a more extensive operation. Curative surgery is offered when the patient is in otherwise good health and the tumor is thought to be localized and can be completely removed. Unfortunately, microscopic spread of cancer cells into the chest wall and diaphragm are common even when such spread cannot be detected by routine tests. Therefore, given the extent of these operations and their very limited success, the exact role of surgery in treating mesothelioma is often debated.
There are two types of operations that may be offered to patients with pleural mesothelioma: pleurectomy/decortication and extrapleural pneumonectomy. Pleurectomy/decortication is usually a palliative (relieves symptoms without curing the cancer) operation in cases where the entire tumor cannot be removed. It involves removal of the pleura, where the majority of the tumor is located. It is effective in controlling effusions (fluid accumulation) and decreasing the pain caused by the cancer.
Extrapleural pneumonectomy is a far more extensive operation and most often used in cases of localized mesothelioma. The operation is technically difficult and performed only by surgeons in large specialized medical centers. It involves removing the pleura, diaphragm, pericardium, and the whole lung on the side of the tumor. The patient must be in overall good health with no other serious illnesses in order to tolerate the large operation. This operation is intended to remove all or most of the cancer and some surrounding tissues as well.
Surgical treatment of peritoneal mesothelioma is often performed either to help relieve symptoms or to attempt to remove the tumor from the wall of the abdomen and other digestive organs. As with pleural mesothelioma, these tumors are often too extensive to remove completely. Similar operations can be performed to remove a mesothelioma from the pericardium (the sac around the heart).

Mesothelioma Radiation

Mesothelioma Radiation Radiation therapy uses high-energy x-rays to kill cancer cells. External beam radiation therapy uses radiation delivered from outside the body that is focused on the cancer. This type of radiation therapy is often used to treat mesothelioma. These treatments are much like getting a diagnostic x-ray except for a longer time. Brachytherapy involves radioactive material being placed directly into the chest or the abdomen at the site of the mesothelioma. Radiation therapy is sometimes used as the main treatment of mesothelioma cancer in some patients, especially those whose general health is too poor to undergo surgery. Adjuvant radiation therapy can be used in addition to surgery to kill small deposits of cancer that cannot be seen and removed during surgery. Palliative radiation therapy can also be used to ease symptoms of mesothelioma such as shortness of breath, pain, bleeding, and difficulty swallowing.
Side effects of radiation therapy may include fatigue and mild skin changes that resemble a sunburn. Often these side effects are temporary. Radiation may also make the side effects of chemotherapy worse. Chest radiation therapy may cause lung damage and lead to difficulty breathing and shortness of breath. Abdominal radiation therapy may cause nausea, vomiting and diarrhea. If you are having any of these side effects of radiation therapy, talk with your doctor since there are ways to help control these symptoms.

Mesothelioma Chemotherapy

Mesothelioma Chemotherapy Chemotherapy is the use of drugs for treating cancer. The drugs can be swallowed in pill form or they can be injected by a needle into a vein or muscle. Chemotherapy is systemic therapy. This means that the drug enters the bloodstream and circulates throughout the body (through the whole system) to reach and destroy the cancer cells.
In treating mesothelioma, these drugs may also be given intrapleurally (directly into the chest cavity), or intraperitoneally (into the abdominal cavity). Depending on the type and stage of mesothelioma, chemotherapy may be given as the primary (main) treatment or as an adjuvant (addition) to surgery.
Several anticancer drugs have been used to treat mesothelioma. The drug most effective when given alone is doxorubicin (Adriamycin). Other drugs that may be given alone include cisplatin and methotrexate. These anticancer drugs are often given in combination to try to increase their effectiveness. Combinations of drugs used in the treatment of mesothelioma include methotrexate and vincristine. Cisplatin, Alimta®, Gemcitabine (Gemzar), Navelbine (Vinorelbine), Carboplatin and Onconase (Ranpirnase) are also effective chemotherapy drugs. Other drugs such as paclitaxel and irinotecan are currently being studied to determine their effectiveness in treating mesothelioma.
Chemotherapy drugs kill cancer cells but also damage some normal cells. Therefore, careful attention must be given to avoiding or minimizing side effects, which depend on the specific drugs, the amount taken, and the length of treatment. Temporary side effects might include nausea and vomiting, loss of appetite, loss of hair, and mouth sores. Because chemotherapy can damage the blood-producing cells of the bone marrow, patients may have low blood cell counts. This can result in an increased risk of infection (due to a shortage of white blood cells), bleeding or bruising after minor cuts or injuries (due to a shortage of blood platelets), and fatigue or shortness of breath (due to low red blood cell counts).
Most side effects disappear once treatment is stopped. There are remedies for many of the temporary side effects of chemotherapy. For example, antiemetic drugs can be given to prevent or reduce nausea and vomiting. If you experience any side effects, be sure to talk with your doctor.

Physical Therapy

Physical Therapy is a complementary therapy that can help asbestos cancer patients recover from surgery or the side effects of mesothelioma chemotherapy or radiation therapy.

Diagnosis and Follow Up Tests


Laboratory Tests
Chromogranin A (CgA) - At A Glance
Why test? Read more . . .
Elevated Plasma Chromogranin A Is the First Indication of Recurrence in Radically Operated Midgut Carcinoid Tumors (Full Text)
Published online: January 29, 2009
Staffan Welin, Mats Stridsberg, Janet Cunningham, Dan Granberg,
Britt Skogseid, Kjell Öberg, Barbro Eriksson, Eva T. Janson
Department of Medical Sciences, Unit of Endocrine Oncology, Clinical   Chemistry, University Hospital, Uppsala, Sweden
Conclusion: P-CgA was the first marker to indicate tumor recurrence in the majorityof radically operated midgut carcinoid patients. To avoid unnecessaryand costly examinations in asymptomatic patients,we suggest that follow-up should comprise measurementsof P-CgA twice a year and annual ultrasonographyuntil P-CgA is elevated or clinical symptoms occur, at which time all efforts should be made to identify recurrent tumorlesions in order to give the patient the best possible treatment which, if possible, should be surgical removal of the recurrence.
NOTE: The importance of Chromogranin A as a neuroendicrine marker has been known and documented in the medical literature for over 20 years.

CgA Medical References
(Share these references with your doctor)
From the Medical Director of the Carcinoid Cancer Foundation
LETTER OF MEDICAL NEED AND EXPLANATION FOR UNUSUAL BLOOD TESTS BEING USED ROUTINELY
Note: The test for Octreotide (Sandostatin) blood levels is still considered experimental by most insurance companies and these companies may therefore NOT pay for this test. For more information regarding this test contact InterScience Institute.
How to Diagnose and Monitor Carcinoid (neuroendocrine tumors): Which Tests and How Often?
Compiled by Susan L. Anderson – September 9, 2002, Updated September 2007
Susan (a carcinoid patient) has compiled a summary of "Which tests and how often" from information provided by Drs. Anthony, Warner and Woltering. After her summary there is additional information from each of these doctors based on their own experience and additional information for the physician. Susan has provided information and support to the carcinoid community since early 1997.
Testing preparation

Preparing for the 24-hour Urine 5HIAA Test

How and Why the 5HIAA Test Is Performed, Normal Range (from Medline Plus, a service of the U.S. National Library of Medicine, National Institutes of Health)
Imaging
(4/28/10) Functional Imaging of NeuroendocrineTumors: A Head-to-Head Comparison of Somatostatin Receptor Scintigraphy, 123I-MIBG Scintigraphy, and 18F-FDG PET
Tina Binderup, Ulrich Knigge, Annika Loft, Jann Mortensen, Andreas Pfeifer, Birgitte Federspiel, Carsten Palnaes Hansen, Liselotte Højgaard, and Andreas Kjaer
Authors’ Affiliations: Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark; Cluster for Molecular Imaging, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
J Nucl Med 2010; 51:704–712
Abstract: Functional techniques are playing a pivotal role in the imaging of cancer today. Our aim was to compare, on a head-to-head basis, 3 functional imaging techniques in patients with histologically verified neuroendocrine tumors: somatostatin receptor scintigraphy (SRS) with 111-Indiethylenetriaminepentaacetic acidoctreotide, scintigraphy with 123I-metaiodobenzylguanidine (MIBG), and 18F-FDG PET. Methods: Ninety-six prospectively enrolled patients with neuroendocrine tumors underwent SRS, 123I-MIBG scintigraphy, and 18F-FDG PET on average within 40 d. The functional images were fused with low-dose CT scans for anatomic localization, and the imaging results were compared with the proliferation index as determined by Ki67. Results: The overall sensitivity of SRS, 123I-MIBG scintigraphy, and 18F-FDG PET was 89%, 52%, and 58%, respectively. Of the 11 SRS-negative patients, 7 were 18F-FDG PET-positive, of which 3 were also 123I-MIBG scintigraphy–positive, giving a combined overall sensitivity of 96%. SRS also exceeded 123I-MIBG scintigraphy and 18F-FDG PET based on the number of lesions detected (393, 185, and 225, respectively) and tumor subtypes. 123I-MIBG scintigraphy was superior to 18F-FDG PET for ileal neuroendocrine tumors, and 18F-FDG PET was superior to 123I-MIBG scintigraphy for pancreaticoduodenal neuroendocrine tumors. The sensitivity of 18F-FDG PET (92%) exceeded that of both SRS (69%) and 123I-MIBG scintigraphy (46%) for tumors with a proliferation index above 15%. Conclusion:The overall sensitivity of 123I-MIBG scintigraphy and 18F-FDG PET was low compared with SRS. However, for tumors with a high proliferation rate, 18F-FDG PET had the highest sensitivity. The results indicate that, although SRS should still be the routine method, 18F-FDG PET provides complementary diagnostic information and is of value for neuroendocrine tumor patients with negative SRS findings or a high proliferation index.
PMID: 20395333 [PubMed - as supplied by publisher]

What is an OctreoScan®?
From the Ohio State University Medical Center website.
Scintigraphic Evaluation of Neuroendocrine Tumors (MIBG, Octreoscan)
from Applied Radiology

Michael W. Hanson, MD
Division of Cardiology at Duke University Medical Center, Durham, NC.
Appl Radiol 30(6):11-17, 2001. © 2001 Anderson Publishing, Ltd

Whole-body 11C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors - comparison with somatostatin receptor scintigraphy and computed tomography

(Full text)
Orlefors H, Sundin A, Garske U, Juhlin C, Oberg K, Langstrom B, Bergstrom M, Eriksson B.
J Clin Endocrinol Metab. 2005 Mar 8
Conclusion: This study indicates that WB-(11)C-HTP-PET can be used as a universal imaging method for detection of NET's. This study also shows that WB-(11)C-HTP-PET is sensitive in imaging small NET-lesions, such as primary tumors, and can in a majority of cases image significantly more tumor lesions than SRS and CT. Presently only available at Uppsala Medical Center, Sweden.

Gallium-68 PET: a new frontier in receptor cancer imaging.

The recent introduction of PET imaging with gallium-68 has major bearings in current and future clinical practice. Its labelling with DOTA compounds has cleared the way for somatostatin receptor imaging with a viable PET agent, with all its inherent imaging advantages compared to single photon imaging. The pre-clinical and clinical applications of this technique has been successful in a variety of tumours, particularly Neuroendocrine Tumors (NETs) and its labelling with other ligands and molecules will improve the management of other tumours and the assessment of infection.